chr9-133428650-G-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_139027.6(ADAMTS13):c.703G>T(p.Asp235Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000228 in 1,315,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D235H) has been classified as Pathogenic.
Frequency
Consequence
NM_139027.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS13 | NM_139027.6 | c.703G>T | p.Asp235Tyr | missense_variant | 7/29 | ENST00000355699.7 | NP_620596.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS13 | ENST00000355699.7 | c.703G>T | p.Asp235Tyr | missense_variant | 7/29 | 1 | NM_139027.6 | ENSP00000347927.2 |
Frequencies
GnomAD3 genomes AF: 0.00000682 AC: 1AN: 146638Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000151 AC: 1AN: 66246Hom.: 0 AF XY: 0.0000257 AC XY: 1AN XY: 38952
GnomAD4 exome AF: 0.00000171 AC: 2AN: 1169112Hom.: 0 Cov.: 33 AF XY: 0.00000350 AC XY: 2AN XY: 572234
GnomAD4 genome AF: 0.00000682 AC: 1AN: 146638Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 71278
ClinVar
Submissions by phenotype
Upshaw-Schulman syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 11, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 235 of the ADAMTS13 protein (p.Asp235Tyr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with thrombotic thrombocytopenic purpura (PMID: 23346910, 26342041, 29554699). ClinVar contains an entry for this variant (Variation ID: 2136831). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ADAMTS13 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ADAMTS13 function (PMID: 26342041, 29554699, 32365113). This variant disrupts the p.Asp235 amino acid residue in ADAMTS13. Other variant(s) that disrupt this residue have been observed in individuals with ADAMTS13-related conditions (PMID: 12753286), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at